(Q34182047)

English

TNF-alpha antagonists for the treatment of Crohn's disease

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

title

TNF-alpha antagonists for the treatment of Crohn's disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

0 references

Kam LY

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249506

retrieved

31 July 2017

Targan SR

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249506

retrieved

31 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249506

retrieved

31 July 2017

published in

Expert Opinion on Pharmacotherapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249506

retrieved

31 July 2017

volume

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249506

retrieved

31 July 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249506

retrieved

31 July 2017

page(s)

615-622

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249506

retrieved

31 July 2017

cites work

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.1.4.615

retrieved

21 January 2018

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.1.4.615

retrieved

21 January 2018

Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.1.4.615

retrieved

21 January 2018

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1517%2F14656566.1.4.615

retrieved

21 January 2018

Identifiers

DOI

10.1517/14656566.1.4.615

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249506

retrieved

31 July 2017

PubMed publication ID

11249506

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11249506

retrieved

31 July 2017

(Q34182047)

TNF-alpha antagonists for the treatment of Crohn's disease

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)